Growth in Mass Spec Sales Helps Proteomic Market Grow Slow and Steady, Report Finds | GenomeWeb
This article has been updated from a previous version, which mistakenly listed Solexa, instead of Sigma-Aldrich, among companies developing proteomics reagents.
 
Despite an ongoing slowdown in the overall growth of proteomic tools, mass spectrometry sales continued to grow, according to a report from a life sciences consulting group.
 
And looking to the future, higher-margin consumables will snare a greater slice of the proteomics revenue pie, it said.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.